{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:55:33Z","timestamp":1785876933362,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Arrhythmogenic cardiomyopathy (ACM) is a heritable cardiac disease with two main features: electric instability and myocardial fibro-fatty replacement. There is no defined treatment except for preventing arrhythmias and sudden death. Detecting causative mutations helps identify the disease pathogenesis and family members at risk. We used whole-exome sequencing to determine a genetic explanation for an ACM-positive patient from a consanguineous family.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>After clinical analysis, cardiac magnetic resonance, and pathology, WES was performed on a two-year-old ACM proband. Variant confirmation and segregation of available pedigree members were performed by PCR and Sanger sequencing. The <jats:italic>PPP1R13L<\/jats:italic> gene was also analyzed for possible causative variants and their hitherto reported conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found a novel homozygous stop-gain pathogenic variant, c.580C\u2009&gt;\u2009T: p.Gln194Ter, in the <jats:italic>PPP1R13L<\/jats:italic> gene, which was confirmed and segregated by PCR and Sanger sequencing. This variant was not reported in any databases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>WES is valuable for the identification of novel candidate genes. To our knowledge, this research is the first report of the <jats:italic>PPP1R13L<\/jats:italic> c.580C\u2009&gt;\u2009T variant. The <jats:italic>PPP1R13L<\/jats:italic> variant was associated with ACM as confirmed by cardiac magnetic resonance and pathology. Our findings indicate that <jats:italic>PPP1R13L<\/jats:italic> should be included in ACM genetic testing to improve the identification of at-risk family members and the diagnostic yield.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02802-7","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T09:06:09Z","timestamp":1659776769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Novel homozygous stop-gain pathogenic variant of PPP1R13L gene leads to arrhythmogenic cardiomyopathy"],"prefix":"10.1186","volume":"22","author":[{"given":"Samira","family":"Kalayinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnaz","family":"Houshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Hesami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Pourirahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"issue":"9671","key":"2802_CR1","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0140-6736(09)60256-7","volume":"373","author":"C Basso","year":"2009","unstructured":"Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289\u2013300.","journal-title":"Lancet"},{"key":"2802_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","volume":"319","author":"D Corrado","year":"2020","unstructured":"Corrado D, Marra MP, Zorzi A, Beffagna G, Cipriani A, De Lazzari M, Migliore F, Pilichou K, Rampazzo A, Rigato I. Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. Int J Cardiol. 2020;319:106\u201314.","journal-title":"Int J Cardiol"},{"issue":"7","key":"2802_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12471-014-0563-7","volume":"22","author":"J Groeneweg","year":"2014","unstructured":"Groeneweg J, van der Heijden J, Dooijes D, van Veen T, van Tintelen J, Hauer R. Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management. Neth Hear J. 2014;22(7):316\u201325.","journal-title":"Neth Hear J"},{"issue":"14","key":"2802_CR4","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/eurheartj\/ehaa141","volume":"41","author":"CA James","year":"2020","unstructured":"James CA, Syrris P, Van Tintelen JP, Calkins H. The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy. Eur Heart J. 2020;41(14):1393\u2013400.","journal-title":"Eur Heart J"},{"issue":"3","key":"2802_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJM198801213180301","volume":"318","author":"G Thiene","year":"1988","unstructured":"Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318(3):129\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"2802_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ejhg.2013.124","volume":"22","author":"WP Te Rijdt","year":"2014","unstructured":"Te Rijdt WP, Jongbloed JD, De Boer RA, Thiene G, Basso C, Van Den Berg MP, Van Tintelen JP. Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC). Eur J Hum Genet. 2014;22(2):293\u2013293.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"2802_CR7","doi-asserted-by":"publisher","first-page":"e003273","DOI":"10.1161\/CIRCGEN.120.003273","volume":"14","author":"CA James","year":"2021","unstructured":"James CA, Jongbloed JD, Hershberger RE, Morales A, Judge DP, Syrris P, Pilichou K, Domingo AM, Murray B, Cadrin-Tourigny J. International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework. Circ Genomic Precis Med. 2021;14(3):e003273.","journal-title":"Circ Genomic Precis Med"},{"issue":"4","key":"2802_CR8","doi-asserted-by":"publisher","first-page":"e000067","DOI":"10.1161\/HCG.0000000000000067","volume":"13","author":"K Musunuru","year":"2020","unstructured":"Musunuru K, Hershberger RE, Day SM, Klinedinst NJ, Landstrom AP, Parikh VN, Prakash S, Semsarian C, Sturm AC. Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association. Circ Genomic Precis Med. 2020;13(4):e000067.","journal-title":"Circ Genomic Precis Med"},{"issue":"6","key":"2802_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacc.2009.11.020","volume":"55","author":"T Xu","year":"2010","unstructured":"Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pillichou K, Scherer SE, Saffitz J, Kravitz J, Zareba W. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2010;55(6):587\u201397.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2802_CR10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.amjcard.2015.07.037","volume":"116","author":"A Lorenzon","year":"2015","unstructured":"Lorenzon A, Pilichou K, Rigato I, Vazza G, De Bortoli M, Calore M, Occhi G, Carturan E, Lazzarini E, Cason M. Homozygous desmocollin-2 mutations and arrhythmogenic cardiomyopathy. Am J Cardiol. 2015;116(8):1245\u201351.","journal-title":"Am J Cardiol"},{"issue":"1","key":"2802_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"Z Xu","year":"2017","unstructured":"Xu Z, Zhu W, Wang C, Huang L, Zhou Q, Hu J, Cheng X, Hong K. Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: a systematic review and meta-analysis. Sci Rep. 2017;7(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"2","key":"2802_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ng1070","volume":"33","author":"D Bergamaschi","year":"2003","unstructured":"Bergamaschi D, Samuels Y, O\u2019Neil NJ, Trigiante G, Crook T, Hsieh J-K, O\u2019Connor DJ, Zhong S, Campargue I, Tomlinson ML. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet. 2003;33(2):162\u20137.","journal-title":"Nat Genet"},{"issue":"5","key":"2802_CR13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.hrthm.2018.11.015","volume":"16","author":"G Poloni","year":"2019","unstructured":"Poloni G, Calore M, Rigato I, Marras E, Minervini G, Mazzotti E, Lorenzon A, Mura IEAL, Telatin A, Zara I. A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in the TP63 gene in patients with arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(5):773\u201380.","journal-title":"Heart Rhythm"},{"issue":"1","key":"2802_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2052.2008.01796.x","volume":"40","author":"M Simpson","year":"2009","unstructured":"Simpson M, Cook R, Solanki P, Patton M, Dennis J, Crosby A. A mutation in NF\u03baB interacting protein 1 causes cardiomyopathy and woolly haircoat syndrome of Poll Hereford cattle. Anim Genet. 2009;40(1):42\u20136.","journal-title":"Anim Genet"},{"issue":"3","key":"2802_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.15252\/emmm.201606523","volume":"9","author":"TC Falik-Zaccai","year":"2017","unstructured":"Falik-Zaccai TC, Barsheshet Y, Mandel H, Segev M, Lorber A, Gelberg S, Kalfon L, Ben Haroush S, Shalata A, Gelernter-Yaniv L. Sequence variation in PPP 1R13L results in a novel form of cardio-cutaneous syndrome. EMBO Mol Med. 2017;9(3):319\u201336.","journal-title":"EMBO Mol Med"},{"issue":"48","key":"2802_CR16","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1093\/eurheartj\/ehv565","volume":"36","author":"JJ McMurray","year":"2015","unstructured":"McMurray JJ. Improving outcomes in heart failure: a personal perspective. Eur Heart J. 2015;36(48):3467\u201370.","journal-title":"Eur Heart J"},{"issue":"9","key":"2802_CR17","doi-asserted-by":"publisher","first-page":"E2403","DOI":"10.1002\/humu.22619","volume":"35","author":"DM Rowczenio","year":"2014","unstructured":"Rowczenio DM, Noor I, Gillmore JD, Lachmann HJ, Whelan C, Hawkins PN, Obici L, Westermark P, Grateau G, Wechalekar AD. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. 2014;35(9):E2403\u201312.","journal-title":"Hum Mutat"},{"issue":"5","key":"2802_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201323.","journal-title":"Genet Med"},{"issue":"18","key":"2802_CR19","doi-asserted-by":"publisher","first-page":"e021987","DOI":"10.1161\/JAHA.121.021987","volume":"10","author":"D Corrado","year":"2021","unstructured":"Corrado D, Zorzi A, Cipriani A, Bauce B, Bariani R, Beffagna G, De Lazzari M, Migliore F, Pilichou K, Rampazzo A. Evolving diagnostic criteria for arrhythmogenic cardiomyopathy. J Am Heart Assoc. 2021;10(18):e021987.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2802_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/cge.13812","volume":"98","author":"H Robinson","year":"2020","unstructured":"Robinson H, Zaklyazminskaya E, Povolotskaya I, Surikova Y, Mallin L, Armstrong C, Mabin D, Benke P, Chrisant M, McDonald M. Biallelic variants in PPP1R13L cause paediatric dilated cardiomyopathy. Clin Genet. 2020;98(4):331\u201340.","journal-title":"Clin Genet"},{"issue":"7","key":"2802_CR21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41418-017-0039-6","volume":"25","author":"Z Dedei\u0107","year":"2018","unstructured":"Dedei\u0107 Z, Sutendra G, Hu Y, Chung K, Slee EA, White MJ, Zhou FY, Goldin RD, Ferguson DJ, McAndrew D. Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders. Cell Death Differ. 2018;25(7):1289\u2013303.","journal-title":"Cell Death Differ"},{"issue":"9","key":"2802_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","volume":"108","author":"JW Gordon","year":"2011","unstructured":"Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB. Circ Res. 2011;108(9):1122\u201332.","journal-title":"Circ Res"},{"issue":"5","key":"2802_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/hmg\/ddi063","volume":"14","author":"BJ Herron","year":"2005","unstructured":"Herron BJ, Rao C, Liu S, Laprade L, Richardson JA, Olivieri E, Semsarian C, Millar SE, Stubbs L, Beier DR. A mutation in NFkB interacting protein 1 results in cardiomyopathy and abnormal skin development in wa3 mice. Hum Mol Genet. 2005;14(5):667\u201377.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"2802_CR24","doi-asserted-by":"publisher","first-page":"E973","DOI":"10.1073\/pnas.1408111112","volume":"112","author":"M Notari","year":"2015","unstructured":"Notari M, Hu Y, Sutendra G, Dedei\u0107 Z, Lu M, Dupays L, Yavari A, Carr CA, Zhong S, Opel A. iASPP, a previously unidentified regulator of desmosomes, prevents arrhythmogenic right ventricular cardiomyopathy (ARVC)-induced sudden death. Proc Natl Acad Sci. 2015;112(9):E973\u201381.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2802_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2011.08.038","volume":"44","author":"W Assaily","year":"2011","unstructured":"Assaily W, Rubinger DA, Wheaton K, Lin Y, Ma W, Xuan W, Brown-Endres L, Tsuchihara K, Mak TW, Benchimol S. ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. Mol Cell. 2011;44(3):491\u2013501.","journal-title":"Mol Cell"},{"issue":"3","key":"2802_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","volume":"4","author":"BN Finck","year":"2006","unstructured":"Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, Harris TE, Lawrence JC Jr, Kelly DP. Lipin 1 is an inducible amplifier of the hepatic PGC-1\u03b1\/PPAR\u03b1 regulatory pathway. Cell Metab. 2006;4(3):199\u2013210.","journal-title":"Cell Metab"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02802-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T09:06:11Z","timestamp":1659776771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02802-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2802"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02802-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the medical histories and the clinical information were collected in Rajaie Cardiovascular Medical and Research Center, Tehran, Iran, in accordance with the Declaration of Helsinki, and the study protocol was approved by the institutional ethics committee (IR.RHC.REC.1399.044). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"359"}}